Novo Nordisk announced the availability of Wegovy® (semaglutide 2.4 mg) (MAL24126014AZ) in Malaysia, an adjunct treatment option for adults living with obesity and overweight who present with at least one weight-related comorbidity.
What an appropriate timing for us girls to start our healthy lifestyle again last weekend after binge eating during Chinese New Year. You know how it feels when being tempted by all the snacks and unavoidable endless gatherings 😉